The board of EDGE MEDICAL-B (02675) has announced its intention to repurchase the company's H-shares.
This move will be made under the general mandate granted to the board by a resolution passed by the company's shareholders at a general meeting held on June 16, 2025.
The board has decided to utilize this share repurchase authorization to buy back H-shares on the open market from time to time, subject to market conditions, with a total value of up to HK$200 million.
According to the repurchase authorization, the number of H-shares to be repurchased must not exceed 10% of the total number of issued H-shares of the company as of its listing date on The Stock Exchange of Hong Kong Limited, excluding any treasury shares.
Comments